Our Research Partners
Physicians from The Johns Hopkins Scleroderma Center work closely with colleagues from around the nation.
The Johns Hopkins Scleroderma Center works collaboratively with faculty from the Johns Hopkins Division of Rheumatology, other members of Johns Hopkins University, and investigators and clinicians from other institutions:
- Michael Simons, M.D., Robert W. Berliner Professor of Medicine, Yale University
- Maureen Mayes, M.D., M.P.H., Professor of Medicine, University of Texas Health Science Center at Houston
- John Varga, M.D., Gallagher Research Professor in Rheumatology, Northwestern University Feinberg School of Medicine
- Virginia D. Steen, M.D., Professor of Medicine, Georgetown University Medical Center
- Michael Whitfield, M.D., Assistant Professor of Genetics, Dartmouth College
- Mary Jo Mulligan-Kehoe, PhD, Research Assistant Professor of Surgery, Dartmouth College
In addition, Johns Hopkins Scleroderma Center physicians and staff collaborate with private industry to develop novel treatments and new tools for studying scleroderma:
- United Therapeutics
- Actelion Pharmaceuticals
- Kinemed
- MedImmune
- Orion Pharmaceuticals
- MPP Group, Inc.
- Bristol-Myers Squibb
- Novartis Pharmaceuticals
- Hoffman – La Roche
